According to WHO report “Gobal data on visual impairment 2010”, worldwide the number of people of all ages visually impaired is estimated to be 285 million, of whom 39 million are blind. With the growth and ageing of the global population increasing the risk that more people acquire vision impairment, age-related and degenerative ophtalmic disease, glaucoma, diabetic macular edema, as well as dry eye, uveitis and many other ocular conditions are important indications in clinical trials.
Ophthalmology clinical studies are highly specialized and are now including new outcomes and measures, in addition to new diagnostic technologies and novel endpoints. OPIS can provide specific expertise and scientific and methodological advice, supporting the Client from the study design phase to the final Clinical Study Report.
More than 45 studies managed
Indications: bilateral cataracts, age-related macular degeneration, blepharitis, diabetic macular edema, choroidal neovascularization, diabetic retinopathy, geographic atrophy, dry eye syndrome, cataract operation, Panuveitis in Behçet's disease, posterior capsule opacity, macular edema, retinitis pigmentosa, retinopathy of prematurity, glaucoma
Phases: Ib/II, II, III, IIIb, IV
Other details: interventional and non-interventional studies, studies on medical devicies, studies on diet supplement, studies in adults and children